Group
Oncolytic virus
Group Profile
| Therapeutic Class | Immunotherapy |
| Drug Class | Oncolytic virus |
| Mechanism of Action | Oncolytic virus |
| Drugs in group | Talimogene Laherparepvec |
Study design
RT–Drug Timing Window
Study design
RT–Drug Timing Window
The data above refer to patients treated with Oncolytic virus as the sole drug class,
excluding any concurrent use of drugs from other groups.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.